Finox Biotech AG is a Swiss company founded in 2007 that focuses on developing and launching high-quality, cost-effective, and easy-to-use fertility products. The company specializes in fertility drugs and innovative, patient-friendly delivery devices with the goal of becoming the pharmaceutical partner of choice in fertility treatments. As the sole entity concentrated solely on fertility products, Finox Biotech AG aims to bring value to patients, IVF specialists, and investors. This is achieved by ensuring safe, effective, fairly priced, and high-quality treatments for patients, as well as offering investment opportunities in a company striving to be a leading player in this sector. The last funding round amounted to Fr.22.00M from BVGroup on 17 September 2013.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Funding Round | Fr.22.00M | 1 |
|
17 Sep 2013 |
No recent news or press coverage available for Finox Biotech AG.
We care about your data, and we'd love to use cookies make your experience better.